Joel C Thompson
Overview
Explore the profile of Joel C Thompson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
301
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Thompson J, Wilson P, Shridas P, Ji A, de Beer M, de Beer F, et al.
Atherosclerosis
. 2017 Nov;
268:32-35.
PMID: 29175652
Background And Aims: Serum amyloid A (SAA) predicts cardiovascular events. Overexpression of SAA increases atherosclerosis development; however, deficiency of two of the murine acute phase isoforms, SAA1.1 and SAA2.1, has...
12.
Wilson P, Thompson J, Yoder M, Charnigo R, Tannock L
J Lipid Res
. 2017 Sep;
58(12):2264-2274.
PMID: 28912302
Animal studies demonstrate that hyperlipidemia and renal lipid accumulation contribute to the pathogenesis of diabetic nephropathy (DN). We previously demonstrated that renal lipoproteins colocalize with biglycan, a renal proteoglycan. The...
13.
Thompson J, Woods G, Arnold M, Elmaraghy C, Kahwash S, Cripe T, et al.
Case Rep Oncol
. 2016 Oct;
9(2):447-453.
PMID: 27721766
Pediatric soft tissue sarcomas of the oral/maxillofacial region are rare neoplasms that present significant difficulty with respect to treatment and local control measures. We report four cases of pediatric oral/maxillofacial...
14.
Thompson J, Jayne C, Thompson J, Wilson P, Yoder M, Webb N, et al.
J Lipid Res
. 2014 Nov;
56(2):286-93.
PMID: 25429103
Serum amyloid A (SAA) has a number of proatherogenic effects including induction of vascular proteoglycans. Chronically elevated SAA was recently shown to increase atherosclerosis in mice. The purpose of this...
15.
Tang T, Thompson J, Wilson P, Yoder M, Mueller J, Fischer J, et al.
J Mol Cell Cardiol
. 2014 Aug;
75:174-80.
PMID: 25093698
Proteoglycans of the arterial wall play a critical role in vascular integrity and the development of atherosclerosis owing to their ability to organize extracellular matrix molecules and to bind and...
16.
Thompson J, Tang T, Wilson P, Yoder M, Tannock L
Atherosclerosis
. 2014 May;
235(1):71-5.
PMID: 24816040
Objective: The response to retention hypothesis of atherogenesis proposes that atherosclerosis is initiated via the retention of atherogenic lipoproteins by vascular proteoglycans. Co-localization studies suggest that of all the vascular...
17.
de Beer M, Wroblewski J, Noffsinger V, Rateri D, Howatt D, Balakrishnan A, et al.
Arterioscler Thromb Vasc Biol
. 2013 Nov;
34(2):255-61.
PMID: 24265416
Objective: Although elevated plasma concentrations of serum amyloid A (SAA) are associated strongly with increased risk for atherosclerotic cardiovascular disease in humans, the role of SAA in the pathogenesis of...
18.
Thompson J, Klima J, Despotovic J, OBrien S
Pediatr Blood Cancer
. 2013 Jul;
60(11):E149-51.
PMID: 23813881
In March 2010, the Food and Drug Administration (FDA) issued a black box warning for anti-D immunoglobulin (anti-D), an approved treatment for immune thrombocytopenia (ITP). It is unknown if and...
19.
Tang T, Wilson P, Thompson J, Nelson C, Yoder M, Tannock L
J Lipid Res
. 2013 Jun;
54(8):2255-2264.
PMID: 23749984
Angiotensin II (angII) accelerates atherosclerosis, but the mechanisms are not fully understood. The aim of this study was to determine whether TGFβ is required for angII-induced atherosclerosis. Ldlr-null mice fed...
20.
Tang T, Thompson J, Wilson P, Nelson C, Williams K, Tannock L
Connect Tissue Res
. 2012 Jul;
54(1):5-13.
PMID: 22834985
Biglycan (BGN), a small leucine-rich proteoglycan, binds the pro-fibrotic cytokine transforming growth factor β (TGFβ) and inhibits its bioactivity in vitro. Nevertheless, it is controversial whether BGN plays an inhibitory...